The largest database of trusted experimental protocols

Anti rxrα

Manufactured by Santa Cruz Biotechnology
Sourced in United States

Anti-RXRα is an antibody product developed by Santa Cruz Biotechnology for the detection of the Retinoid X Receptor alpha (RXRα) protein. RXRα is a member of the nuclear receptor superfamily and functions as a transcription factor, playing a crucial role in various biological processes. The Anti-RXRα antibody can be used in techniques such as Western blotting, immunoprecipitation, and immunohistochemistry to identify and quantify the expression of RXRα in biological samples.

Automatically generated - may contain errors

11 protocols using anti rxrα

1

Transcription Factor Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNAP assay was performed as previously described [23] (link). The biotin-labeled DNA probes (Sigma-Aldrich) were annealed to complementary oligonucleotides. COS-7 cells were transfected with 1 µg of expression vectors using LipofectAmine 2000 (Invitrogen), according to the manufacturer's instructions. Transfected COS-7 cells or nuclear fractions of BM-DCs were lysed or diluted with DNAP binding buffer [25 mM Tris-HCl (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.25% NP-40, 1 mM DTT and Complete Protease Inhibitor Cocktail (Nacalai Tesque)], respectively. Cell debris was removed by centrifugation (20,000×g) for 10 min. Lysates were first incubated with Streptavidin-Sepharose beads (GE Healthcare) for 30 min to eliminate nonspecific binding and then incubated with 1.5 µg of poly(dI-dC) and 2 µg of biotinylated DNA probe for 1 h at 4°C. Streptavidin-Sepharose beads were then added and incubated with these mixtures for an additional 30 min at 4°C. After washing the beads three times in DNAP binding buffer, precipitated proteins were eluted in SDS-PAGE sample buffer. Samples were analyzed SDS-PAGE followed by Western blot analysis using anti-Sp1 (Santa Cruz Biotechnology), anti-Myc (Nacalai Tesque), anti-RARα (Santa Cruz Biotechnology), and anti-RXRα (Santa Cruz Biotechnology) Abs.
+ Open protocol
+ Expand
2

Quantitative Protein-DNA Interaction Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A master mixture of the recombinant proteins (0.1 to 0.5 μg/150 μl) and biotin-labeled DNAs (1 pMol/150 μl) were prepared with binding buffer [10 mM Hepes pH 7.9, 2.5 mM MgCl2, 50 mM KCl, 150 mM NaCl, 5% glycerol, 1 mM DTT, 0.1% IGEPAL CA-630]. The master mixture was dived into 1.5 ml tubes (150 μl/tube). Then streptavidin-beads (15 μl (50% slurry)/150 μl) and 10- and 30-fold excessive unlabeled competitor DNAs (10 to 30 pMol) were added. After 2 hours of rotation, the recovered proteins were washed 3 times with 1 ml of binding buffer and subjected to Western blot analyses with anti-PPARα (Cayman, #101710) and anti-RXRα (Santa Cruz, ΔN197, sc-774) antibodies. For incubation with WY14,643, 1 μM WY14,643 was added to the binding buffer used for the initial incubation and washing. The signal density of Western blot analyses was quantified with the ImageJ program. The signal density without a competitor was defined as 100.
+ Open protocol
+ Expand
3

Protein Expression Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
After isolation, content determination and electrophoresis, proteins were elettroblotted [46 (link)] and incubated with a polyclonal rabbit anti-CRBP-1, anti-Creb1, anti-CD44, anti-c-Jun, anti-Nox4, anti-p53, anti-RXRα, anti-RARα (Santa Cruz Biotechnology), anti-RARβ, (Abcam), anti-phosphorylated v-akt murine Jesi AN, Italy) and then sequenced using PyroMark Q24 thymoma viral oncogene homolog (pAkt Ser473), anti-AKT (pan), anti-phosphorylated extracellular-signal-regulated kinases (pErk1/2), anti-phosphorylated epidermal growth factor receptor (anti-EGFR Thr669), anti-EGFR antibody (Cell Signaling Technology, Danvers, MA, USA), anti-keratin 5 (clone H-40, Santa Cruz Biotechnology), mouse anti-vimentin (clone J144, Abcam), anti-keratin 14 (LL001, Santa Cruz Biotechnology) and anti-total tubulin antibody (Sigma-Aldrich). Revelation and densitometric blot analysis were performed in three independent experiments and Akt and EGFR activity expressed as phospho/total protein ratio [47 (link)].
+ Open protocol
+ Expand
4

TR Binding to BSSP4 Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
ChIP assays were performed to examine the interactions between TR and TRE on the BSSP4 promoter
[45 (link)]. HepG2-TRα1 cells treated with 10 nM T3 for 24 h or left untreated were harvested and cross-linked with 1% formaldehyde for 10 min at room temperature in DMEM medium. Reactions were terminated by adding 0.125 M glycine. Subsequently, cell lysates were washed three times with PBS, and resuspended in lysis buffer (150 mM NaCl, 5 mM EDTA, 50 mM Tris (pH 8.0), 0.1% SDS and 0.1% sodium deoxycholate) containing three protease inhibitors (1 mM PMSF, aprotinin, and leupeptin). Cell lysates were sonicated with a Misonix Sonicator 3000 Homogenizer (Mandel Scientific Company Inc., Guelph, ON, Canada) to disrupt chromatin. Sonicated DNA was between 200 and 1000 bp in length. Products were precleared with 60 μl protein A/G agarose (Sigma Chemicals, St. Louis, MO) for 2 h at 4°C. Complexes were immunoprecipitated with anti-TR (kindly provided by the laboratory of Dr. S-Y Cheng at the National Cancer Institute), anti-RXRα (Santa Cruz Biotechnology, Santa Cruz, CA) and anti-IgG antibodies (R & D Systems, Inc., Minneapolis, MN). The 100 bp fragment of the BSSP4 promoter containing the predicted TRE region was amplified via PCR with the forward primer, 5′- CTCCAGGAACGACAGGAGGGCG - 3′, and reverse primer, 5′-GCCTGGGTTTGGAGAGGCTGAAGTC- 3′.
+ Open protocol
+ Expand
5

ChIP Analysis of Immt Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
ChIP analysis was performed according to the manufacturer’s instructions (Millipore, Darmstadt, Germany). Briefly, HepG2 cells were crosslinked with 1% formaldehyde for 10 min at room temperature and then quenched with 125 mM glycine. The cells were resuspended and sonicated in SDS lysis buffer. Lysates were incubated overnight at 4 °C with the following antibodies: anti-mouse IgG (Santa Cruz, Dallas, USA), anti-VDR (Santa Cruz) and anti-RXRα (Santa Cruz). Protein G agarose was added to form immunocomplexes, which were washed and subjected to elution. The samples were treated with RNase A and proteinase K. DNA was subsequently purified using PCR purification spin columns (QIAGEN, Hilden, Germany). The primers used to amplify the Immt promoter regions were designated R1 (−3986 to −3203), R2 (−3157 to −2323), R3 (−2312 to −1724), R4 (−1845 to −1159), R5 (−1179 to −550) and R6 (−574 to 115) from the transcription start site (TSS). The primers are listed in Supplementary Table 1.
+ Open protocol
+ Expand
6

Protein Expression Analysis by Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
After isolation, content determination and electrophoresis, proteins were elettroblotted [29 (link)] and incubated with a polyclonal rabbit anti-CRBP-1, anti-RXRα, anti-RARα (1:500, Santa Cruz Biotechnology, USA), anti-RARβ, anti-RARγ, anti-cytokeratin-5/6, anti-cytokeratin-10 (1:500, Abcam, Cambridge, UK), anti-phosphorylated-AKT (pAKT Ser473), anti-AKT, anti-phosphorylated ERK1/2, anti-phosphorylated EGFR (Thr669) and mouse anti-total tubulin antibody (Sigma-Aldrich), followed from horseradish peroxidase conjugate goat anti-rabbit or anti-mouse IgGs (Pierce, Rockford, USA). Specific complexes were revealed and quantified as reported [29 (link)] in three independent experiments. AKT and EGFR activity expressed as phospho/total protein ratio [30 (link)].
+ Open protocol
+ Expand
7

Western Blot Analysis of Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole-cell lysates were prepared as described previously [4 ], by lysing the cells in boiling buffer (1% SDS, 1 mM sodium vanadate, 10 mM Tris [pH 7.4]) in the presence of complete protease inhibitor mixture (Roche diagnostics). The viscosity of the samples was reduced by sonication. Whole-cell lysates or immunoprecipitation samples were separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE), and electroblotted onto a nitrocellulose membrane (GE Healthcare). After incubation for one hour at RT with 5% nonfat milk in Tris-buffered saline (TBS)–0.1% Tween-20, membranes were incubated overnight with the primary antibody diluted in TBS-milk-Tween, washed, incubated with the secondary antibody for 30 minutes at RT, and washed again before analysis with a luminol detection kit (Santa Cruz biotechnology) and chemidoc analyser (Bio-Rad, Marnes-la-coquette, France). Relative quantification was performed using ImageLab software. The following mouse mAbs were used: anti–β-actin (A1978) from Sigma-Aldrich, anti- LXRβ (PP-K8917) from R&D sytems. We also used rabbit pAbs anti-RXRα (ΔN197 - Santa Cruz biotechnology) and anti-GFP (PA1-980A – Fisher scientific, Illkirch, France). Secondary Abs HRP-conjugated polyclonal goat anti-mouse and swine anti-rabbit immunoglobulins (Jackson ImmunoResearch, Suffolk, UK) were also used.
+ Open protocol
+ Expand
8

Molecular Profiling of Intestinal Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mucosal lining of ApcLoxP/+-Cdx2 mice (n=7 per group) and ApcMin/+ mice (n=3 per group) was stripped for subsequent analysis. The tissue was homogenized in radioimmune precipitation assay buffer with complete Mini protease and PhosSTOP phosphatase inhibitor (Roche Diagnostics, Mannheim, Germany). The tissue lysates were separated on polyacrylamide gels (BioRad) for Western blot analysis. The following primary antibodies were used: anti-COX2, anti-Bcl-2, anti-β-catenin, anti-EGFR, anti-p-EGFR, and anti-Cyclin D1 (Cell Signaling, Beverly, MA), anti-p-NFκB p65, and anti-RXRα (Santa Cruz, Dallas, TX). Goat anti-mouse (1:6000) or goat anti-rabbit (1:6000) secondary antibodies were used (Abcam, Cambridge, MA). The membranes were detected by the Enhanced Chemiluminescence Detection kit (GE Healthcare, Chicago, IL)
+ Open protocol
+ Expand
9

Quantification of Cell Signaling Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stably transfected MCF-7 and MDA-MB-231 cells or peptide-treated wild type MCF-7 and MDA-MB-231 cells were collected and lysed using an RIPA buffer. The BCA (Pierce kit #23225) method was used for protein quantitation of the whole cell lysates. The whole cell lysates were subjected to SDS-PAGE and Western blotting. Specific proteins were probed using anti-Sin3A (cat#sc-5299, Santa Cruz Biotechnology, Dallas, TX, USA), anti-RARα (cat# sc-515796), anti-RXRα (cat#sc-515929, Santa Cruz Biotechnology, Dallas, TX, USA) and anti-RARβ (cat# sc-56864 Santa Cruz Biotechnology, Dallas, TX, USA), followed by incubation with HR0 conjugated anti-mouse antibodies (cat# 7076, Cell Signaling technologies, Denvers, MA, USA). The bands were visualized by chemiluminescence.
+ Open protocol
+ Expand
10

Western Blot Analysis of Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting analysis was performed as described previously (22 (link)). The following primary antibodies were used: anti-RXRα (rabbit IgG, 1:500 dilution, sc-553; Santa Cruz Biotechnology, Inc., Santa Cruz, CA), anti-β-catenin (mouse IgG, 1:8000 dilution, #610154; BD Transduction, San Jose, CA), anti-Rb (mouse IgG, 1:500 dilution, #554136; BD Pharmingen, San Jose, CA), anti-cyclin D1 (rabbit IgG, 1:1000 dilution, sc-753; Santa Cruz Biotechnology), anti-proliferating cell nuclear antigen (PCNA) (mouse IgG, 1:2000 dilution, #2586; Cell Signaling Technology, Danvers, MA) and anti-GAPDH (rabbit IgG, 1:2000 dilution, #2118; Cell Signaling Technology).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!